Cargando…
Advances and considerations in AD tau-targeted immunotherapy
The multifactorial and complex nature of Alzheimer’s disease (AD) has made it difficult to identify therapeutic targets that are causally involved in the disease process. However, accumulating evidence from experimental and clinical studies that investigate the early disease process point towards th...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6980703/ https://www.ncbi.nlm.nih.gov/pubmed/31841678 http://dx.doi.org/10.1016/j.nbd.2019.104707 |